Description (English)

"Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, and lactams, alprazolam ""INN"", camazepam ""INN"", chlordiazepoxide ""INN"", clonazepam ""INN"", clorazepate, delorazepam ""INN"", diazepam ""INN"", estazolam ""INN"", ethyl loflazepate ""INN"", fludiazepam ""INN"", flunitrazepam ""INN"", flurazepam ""INN"", halazepam ""INN"", lorazepam ""INN"", lormetazepam ""INN"", mazindol ""INN"", medazepam ""INN"", midazolam ""INN"", nimetazepam ""INN"", nitrazepam ""INN"", nordazepam ""INN"", oxazepam ""INN"", pinazepam ""INN"", prazepam ""INN"", pyrovalerone ""INN"", temazepam ""INN"", tetrazepam ""INN"" and triazolam ""INN"", salts thereof and azinphos-methyl ""ISO"") : Other : Active pharmaceutical ingredient of Bortezomib"